About
Mighty Therapeutics, through its wholly owned subsidiary Stealth BioTherapeutics Inc., develops therapies targeting mitochondrial dysfunction to treat diseases related to mitochondrial impairment.
Explore Mighty Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.